These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Altered astrocyte morphology and vascular development in dystrophin-Dp71-null mice. Giocanti-Auregan A; Vacca O; Bénard R; Cao S; Siqueiros L; Montañez C; Paques M; Sahel JA; Sennlaub F; Guillonneau X; Rendon A; Tadayoni R Glia; 2016 May; 64(5):716-29. PubMed ID: 26711882 [TBL] [Abstract][Full Text] [Related]
3. AAV-mediated gene delivery in Dp71-null mouse model with compromised barriers. Vacca O; Darche M; Schaffer DV; Flannery JG; Sahel JA; Rendon A; Dalkara D Glia; 2014 Mar; 62(3):468-76. PubMed ID: 24382652 [TBL] [Abstract][Full Text] [Related]
4. Glio-vascular modifications caused by Aquaporin-4 deletion in the mouse retina. Nicchia GP; Pisani F; Simone L; Cibelli A; Mola MG; Dal Monte M; Frigeri A; Bagnoli P; Svelto M Exp Eye Res; 2016 May; 146():259-268. PubMed ID: 27018215 [TBL] [Abstract][Full Text] [Related]
5. Aquaporin 4 knockdown exacerbates streptozotocin-induced diabetic retinopathy through aggravating inflammatory response. Cui B; Sun JH; Xiang FF; Liu L; Li WJ Exp Eye Res; 2012 May; 98():37-43. PubMed ID: 22449442 [TBL] [Abstract][Full Text] [Related]
6. AAV-mediated gene therapy in Dystrophin-Dp71 deficient mouse leads to blood-retinal barrier restoration and oedema reabsorption. Vacca O; Charles-Messance H; El Mathari B; Sene A; Barbe P; Fouquet S; Aragón J; Darche M; Giocanti-Aurégan A; Paques M; Sahel JA; Tadayoni R; Montañez C; Dalkara D; Rendon A Hum Mol Genet; 2016 Jul; 25(14):3070-3079. PubMed ID: 27288449 [TBL] [Abstract][Full Text] [Related]
7. Kir4.1 and AQP4 associate with Dp71- and utrophin-DAPs complexes in specific and defined microdomains of Müller retinal glial cell membrane. Fort PE; Sene A; Pannicke T; Roux MJ; Forster V; Mornet D; Nudel U; Yaffe D; Reichenbach A; Sahel JA; Rendon A Glia; 2008 Apr; 56(6):597-610. PubMed ID: 18286645 [TBL] [Abstract][Full Text] [Related]
8. Protection of Glial Müller Cells by Dexamethasone in a Mouse Model of Surgically Induced Blood-Retinal Barrier Breakdown. Siqueiros-Marquez L; Bénard R; Vacca O; Charles-Messance H; Bolaños-Jimenez R; Guilloneau X; Sennlaub F; Montañez C; Sahel JA; Rendon A; Tadayoni R; Giocanti-Aurégan A Invest Ophthalmol Vis Sci; 2017 Feb; 58(2):876-886. PubMed ID: 28159978 [TBL] [Abstract][Full Text] [Related]
9. Functional implication of Dp71 in osmoregulation and vascular permeability of the retina. Sene A; Tadayoni R; Pannicke T; Wurm A; El Mathari B; Benard R; Roux MJ; Yaffe D; Mornet D; Reichenbach A; Sahel JA; Rendon A PLoS One; 2009 Oct; 4(10):e7329. PubMed ID: 19809515 [TBL] [Abstract][Full Text] [Related]
12. Blood-retinal barrier disruption and ultrastructural changes in the hypoxic retina in adult rats: the beneficial effect of melatonin administration. Kaur C; Sivakumar V; Yong Z; Lu J; Foulds WS; Ling EA J Pathol; 2007 Aug; 212(4):429-39. PubMed ID: 17582234 [TBL] [Abstract][Full Text] [Related]
13. Decursin inhibits VEGF-mediated inner blood-retinal barrier breakdown by suppression of VEGFR-2 activation. Kim JH; Kim JH; Lee YM; Ahn EM; Kim KW; Yu YS J Cereb Blood Flow Metab; 2009 Sep; 29(9):1559-67. PubMed ID: 19536074 [TBL] [Abstract][Full Text] [Related]
14. Lack of dystrophin protein Dp71 results in progressive cataract formation due to loss of fiber cell organization. Fort PE; Darche M; Sahel JA; Rendon A; Tadayoni R Mol Vis; 2014; 20():1480-90. PubMed ID: 25489223 [TBL] [Abstract][Full Text] [Related]
15. Potential role of A2A adenosine receptor in traumatic optic neuropathy. Ahmad S; Fatteh N; El-Sherbiny NM; Naime M; Ibrahim AS; El-Sherbini AM; El-Shafey SA; Khan S; Fulzele S; Gonzales J; Liou GI J Neuroimmunol; 2013 Nov; 264(1-2):54-64. PubMed ID: 24090652 [TBL] [Abstract][Full Text] [Related]
16. Suppression of diabetes-induced retinal inflammation by blocking the angiotensin II type 1 receptor or its downstream nuclear factor-kappaB pathway. Nagai N; Izumi-Nagai K; Oike Y; Koto T; Satofuka S; Ozawa Y; Yamashiro K; Inoue M; Tsubota K; Umezawa K; Ishida S Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):4342-50. PubMed ID: 17724226 [TBL] [Abstract][Full Text] [Related]
17. Methallothionein-3 contributes to vascular endothelial growth factor induction in a mouse model of choroidal neovascularization. Choi JA; Hwang JU; Yoon YH; Koh JY Metallomics; 2013 Oct; 5(10):1387-96. PubMed ID: 23962989 [TBL] [Abstract][Full Text] [Related]
18. Effects of peroxisome proliferator-activated receptor gamma and its ligand on blood-retinal barrier in a streptozotocin-induced diabetic model. Muranaka K; Yanagi Y; Tamaki Y; Usui T; Kubota N; Iriyama A; Terauchi Y; Kadowaki T; Araie M Invest Ophthalmol Vis Sci; 2006 Oct; 47(10):4547-52. PubMed ID: 17003451 [TBL] [Abstract][Full Text] [Related]
19. Changes in ocular aquaporin-4 (AQP4) expression following retinal injury. Dibas A; Yang MH; He S; Bobich J; Yorio T Mol Vis; 2008 Sep; 14():1770-83. PubMed ID: 18836575 [TBL] [Abstract][Full Text] [Related]
20. Role of nonproteolytically activated prorenin in pathologic, but not physiologic, retinal neovascularization. Satofuka S; Ichihara A; Nagai N; Koto T; Shinoda H; Noda K; Ozawa Y; Inoue M; Tsubota K; Itoh H; Oike Y; Ishida S Invest Ophthalmol Vis Sci; 2007 Jan; 48(1):422-9. PubMed ID: 17197563 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]